Shares of Moderna dropped 3.71% to $124.84 at 14:10 EST on Tuesday, following last session’s downward trend. NASDAQ Composite is rising 1.41% to $13,181.83, after two consecutive sessions in a row of losses. This seems, up to now, an all-around positive trend trading session today.
Moderna’s last close was $129.65, 42.98% under its 52-week high of $178.50.
Moderna’s sales growth is 1986.4% for the present quarter and 19117.5% for the next. The company’s growth estimates for the ongoing quarter and the next is 18.9% and 660%, respectively.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s last day, last week, and last month’s average volatility was a negative 0.05%, a positive 2.87%, and a negative 0.64%, respectively.
Moderna’s last day, last week, and last month’s high and low average amplitude percentage was 5.30%, 6.39%, and 8.17%, respectively.
Moderna’s Stock Yearly Top and Bottom Value
Moderna’s stock is valued at $124.84 at 14:10 EST, way below its 52-week high of $178.50 and way higher than its 52-week low of $17.91.
Moderna’s Moving Average
Moderna’s worth is under its 50-day moving average of $133.89 and way above its 200-day moving average of $88.29.